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Clinical Trials Management System (CTMS) to Modernize
Baystate Research Operations
Baystate Health has
begun the implementation
of the new OnCore
clinical trials management
system (CTMS). The
CTMS is a online software
system used to plan,
manage, and track clinical
trials in clinical research.
This system will create
a centralized digital
source of consistent,
valid, and available data
to inform and advance
clinical research -and
ultimately advance the
care of the people in our
communities.
The combination of
two tools creates the
CTMS: OnCore and
Power Trials. OnCore
communicates with
Power Trials and tracks
patients in a study. Power
Trials is a module within
the Cerner system that
links trial activity to the
CIS electronic health
record. The two systems
assure that patients are
identified as participating
in the trial, orders are
placed appropriately, and
charges are filtered so
that the correct charges

go to the correct payor.
Most health systems
around the country use a
CTMS and it has become
the industry standard.
Among the many system

will no longer need to
check every bill for every
patient visit. Over the first
year, patient bills for a
small sample of visits will
continue to be checked

will be documented and
validated to be ready for
implementation. Once
the assembly of the
workflows is complete,
the execution of the

benefits for the research
community:
•Pre-built Power Plans for
research visits will make
CIS documentation easier
and more standardized.
•Billable events will now
be documented in the
CTMS, replacing the
requirement to send
these documents to the
Sponsored Programs
Administration (SPA).
•Once the system is
validated, clinical research
coordinators (CRCs)

to ensure the CTMS is
working correctly.
•The CTMS will generate
reports for the CRCs and
investigators to examine
study operations and
subject flow closer to
real-time.
The implementation of
the CTMS is organized
into three phases. The
first phase will see
the configuration and
integration of the OnCore
and Power Trials systems.
In addition, all workflows

training plan will begin.
During this phase,
everyone involved in the
CTMS will learn about
the new processes and
how to utilize the tools
available to them. The
third and final phase,
expected to begin in the
fall, will be a pilot launch
of the CTMS. The pilot
will include 17-18 select
studies from the clinical
trial office, emergency
medicine, critical care,
and heart & vascular

Research Question? Call the Office of Research at our central number: 413-794-3391

departments. Lessons
learned from those
pilots will be leveraged
and incorporated into a
broader launch.
The project sponsors
are Jennifer Pacheco,
MPH, CIM, CIP, Director
of Healthcare Research
Compliance and Chief
Research Officer, Melissa
Quintero, Director of
Sponsored Programs
Administration and
Peter Friedmann, MD,
MPH, DFASAM, FACP,
Chief Research Officer
and Endowed Chair for
Clinical Research.
The CTMS will
modernize our research
processes, streamline
our operations, reduce
redundant, manual work,
ensure regulatory and
billing compliance, and
help us manage our
research portfolio. “The
current manual approach
limits our ability to gauge
research performance
at Baystate”, says
Friedmann. “The CTMS
will help move us towards
the next level of research
excellence”.
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Select Recent Awards
JOANNA BEACHY, MD, An Open-label, Multicenter, Randomized,
Controlled Study in Spontaneously
Breathing Preterm Neonates with
Respiratory Distress Syndrome
to Compare Two Procedures for
Porcine Surfactant Administration.
Covance, Inc.
NORMAN DESCHAINE, 2022
Connecticut River Valley Farmworkers’ Health Program (CRVHP). MA
League Community Hlth Cntrs.
JOELI HETTLER, MD, MA DPH
Pedi Emergency Grant. MA Dept. of
Public Health (DPH).
QUINN PACK, MD, Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers
with Cardiopulmonary Disease. Nat.
Institutes of Health (NIH).
AMIR LOTFI, MD, A Multi-center
Randomized-Controlled Trial to
Evaluate the Safety and Feasibility
of the Delivery of Intracoronary Hyperoxemic Supersaturated Oxygen
Therapy for 60 Minutes in Patients
with St Elevation Myocardial Infarction (STEMI) and Cardiogenic Shock
A. Therox Inc.

NEENA QASBA, MD, Acceptability
and Feasibility of Integration of
Doulas in Perinatal Care for Black
Birthing People. Health Policy Commission.
WAEL SAYEJ, MD, A Phase 3,
Multicenter, Randomized Study with
2 Different Doses of Prucalopride
Administered to Male and Female
Pediatric Subjects Aged 6 Months
to 17 Years with Functional Constipation, Consisting of a 12-week
Double-blind, Placebo-controlled
Part (Part A). Takeda Development
Center Americas, Inc.
MARK TIDSWELL, MD, Novel
Experimental COVID Therapeutic
Agents Targeting RAAS (NECTAR).
Vanderbilt University Medical Center.
RUBEN VAIDYA, MD, Race,
COVID-19, and Health Outcomes
Among Individuals Born Preterm.
The University of North Carolina at
Chapel Hill.
GOTTFRIED SCHLAUG, MD, Validation of Early Prognostic Data for
Recovery Outcomes after Stroke for
Future, Higher Yield Trials (VERIFY).
University of Cincinnati.

News from UMass CCTS
EVENTS
Public Engagement Workshop:
Communicating Statistical/Numerical Information Effectively
Presented by Ezra Markowitz, PhD
Friday, April 29th, 2022,
10am-12pm, Via Zoom
Do you often work with highly technical, numerical and/or statistical
information but struggle with how
to communicate it effectively to
non-experts? Do you find that your
audiences often misunderstand or
misuse numerical or statistical information in their decision-making? In
this workshop, we will explore and
practice concrete steps you can
take as a communicator to improve
your communication of numerical or
statistical information with diverse
audiences.
Register at https://bit.ly/37MkclJ
Population Health Sciences:
Opportunities to Advance Health
Equity Through Implementation
Science
Presented by Dr. Rachel Shelton,
ScD, MPH
Monday, May 9th, 2022,
12pm-1pm, Via Zoom
Register at https://bit.ly/3viWTI2

Password: 717383
EDUCATION
Transdisciplinary Training in Cardiovascular Research T32 Training
Program
In collaboration with the Division of
Cardiovascular Medicine, the Department of Population and Quantitative Health Sciences (PQHS) has
established a NHLBI-funded T32
program with the aim of producing
a new generation of investigators
who have the enthusiasm, knowledge, and skills to make meaningful
contributions to cardiovascular
research across the translational
spectrum. Directed by Catarina
Kiefe, MD, PhD (PQHS) and Kevin
Donahue, MD (Cardiovascular Medicine), the program is truly transdisciplinary, with investigators working
together to expand knowledge
beyond discipline-based concepts,
theories, and methods.
For eligibility information and to
apply: Contact the Department of
Population and Quantitative Health
Sciences at 508-856-8999 or email
to rebecca.gigliello@umassmed.
edu

The Department of Healthcare Delivery & Population Sciences established at
UMass Chan Medical School-Baystate
The Department of Healthcare
Delivery & Population Sciences
has been established at
UMass Chan Medical School –
Baystate under the leadership
of founding chair and professor
Peter Lindenauer, MD, MSc.
The designation transforms the
former Institute for Healthcare
Delivery and Population
Sciences from a division within
the UMass Chan-Baystate Office
of Research to the status of
formal academic department.
“The Institute has been
promoted into a new department
to help Baystate build the
research capacity and expertise
necessary to optimize and
evaluate its programs and
services in healthcare delivery
and population health,” says
Chief Research Officer Dr.
Peter Friedmann. Among the
Department’s key goals are:
- Recruitment and retention of
outstanding clinical and nonclinical faculty.

- Strengthening the local
mentoring environment.
- Promoting alignment across
academic departments on the
UMass Chan Medical School
Worcester and Springfield
campuses.
- Rigorous evaluation of
population health initiatives at
Baystate Health.
- Helping Baystate Health
realize its vision of becoming a
learning health system.
- Helping Baystate Health
achieve its goal of promoting
greater health equity in the
communities we serve.
“The department has a
tripartite mission that includes
research, education, and service
to Baystate Health,” says Dr.
Lindenauer. “The research that
we do is aimed at improving the
quality of care that we deliver
to patients, improving the value
of care, and reducing health
disparities that exist on the basis
of race, ethnicity, gender, sexual

orientation, socioeconomic
status, and geography.”
The department will also
provide educational and
research opportunities for UMass
Chan-Baystate students through
lectures, mentorship, and
capstone projections.
Dr. Lindenauer, Assistant
Dean for Population Health
at UMass Chan-Baystate, had
directed the Institute since its
earlier incarnation as the Center
of Quality of Care Research.
“Finally, we provide service to
the organization by embedding
health care delivery researchers
into clinical operations to provide
methodologic support around
the design and evaluation of
health system interventions
intended to improve quality,
safety, value, or patient
experience,” says Dr. Lindenauer.
“We have a staff comprised
of research assistants, research
coordinators, project managers,
and biostatisticians who are all

Peter Lindenauer, MD, MSc

involved in the work we do,”
added Dr. Lindenauer. “We do
this research in collaboration
with partners at UMass Chan
Medical School in Worcester,
UMass Amherst, communitybased organizations in our
region and with medical schools
and universities around the
country.”
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New study puts collaborative care team in hospital setting to take
care of patients with Opioid Use Disorder
In the past decade,
hospitalizations for Opioid
Use Disorder (OUD) nearly
doubled. Patients admitted to
the hospitals with an underlying
OUD in general, rarely receive
evidence-based treatment for
OUD when hospitalized. A new
study at Baystate Health will
evaluate whether a collaborative
care team in a hospital setting
improves post-discharge
care compared to usual care
in patients with OUD. “The
purpose of this research is to
enhance care for substance
use disorder,” says Natanael
Velez, MSW, LCSW, clinical
research assistant and care
manager at Baystate Health. “It’s
a population that continues to
grow, so how do we treat it?”
START (Substance Use
Treatment and Recovery Team;
site PI Peter Friedmann) is a
multi-site, randomized trial
that adapts the principles of
collaborative care to the hospital
setting. Collaborative care

requires a team of professionals
with complementary skills who
work together to care for a
population of patients with a
common condition.

Natanael Velez, MSW, LCSW

The START consists of an
addiction medicine specialist
and a care manager who will
use evidence-based tools to
decrease barriers to medication

for opioid use disorder (MOUD)
and link patients to appropriate
post-discharge OUD care. “This
collaboration between a care
manager giving lots of

Stephen Ryzewicz, MD

information and support, and an
addiction medicine specialist,
we hope leads to better
engagement with on-going care
even after the hospital stay” says

Greetings from the New Managing Editor
Hello readers,
My name is Matthew Hamel and I am the new
Digital Content Analyst for the Offices of Faculty
Affairs and Research here at UMass Chan Baystate. I joined the Baystate team in November
2021 and am excited to be handling The Innovator
as the writer, editor, and designer of this quarterly
publication.
I’ve been a resident of Western Mass my
entire life. I graduated from Our Lady of the Elms
College in 2010 with a BA in computer information
technology. Prior to stepping into this position, I
worked as a graphic artist and digital marketing
manager. In that role, I learned to be thorough and
pay close attention to the details. I believe those
skills will help me succeed in delivering the high-quality publication you have
all come to expect. When I’m not working full time, I enjoy taking my dog on
hikes, golfing, woodworking, reading, and going to concerts.
I look forward to keeping you all informed about the impactful research
happening throughout the Baystate Health system. I hope you enjoy this
edition as much as I enjoyed putting it together. I’d also like to take the time to
extend an invitation to the community of readers at Baystate Health. If anyone
has any story ideas for The Innovator, please feel free to send me an email
at matthew.hamel@baystatehealth.org. We would be happy to consider your
ideas!
Cheers,

Matt

Stephen Ryzewicz, MD, Medical
Director and Addiction Medicine
Consultant at Baystate Health.
A total of 414 patients will be
randomized from Cedars-Sinai
Medical Center in Los Angeles,
CA, The University of New
Mexico Hospital in Albuquerque,
NM and Baystate Medical Center
in Springfield, MA. “We are
hoping to enroll 139 participants
at our site” says Natanael Velez.
If the aim of the research
is achieved, the investigators
will learn whether this model of
care increases OUD treatment
delivery in general medical
hospitals and decreases the
subsequent effects of untreated
OUD. “I think people are waiting
for studies like ours to provide
additional information and
hopefully reinforce future care”
says Dr. Ryzewicz. If effective,
this translational model may
be used to increase utilization
of evidence-based practices
for other substance use and
behavioral health disorders.

Welcome to our new
research staff!
CTO:

BACF:

Gerard Coly, Clinical Trials
Program Director

Kelly Corrigan, Veterinary
Technician

Shaula Paul, Clinical
Research Assistant II

OFFICE OF RESEARCH:

Nataneal Velez, Clinical
Research Assistant II
Jessica Vegerano, Clinical
Research Coordinator I
HRPP/IRB:

Matthew Hamel, Digital
Content Analyst
Deb Leclerc, Program
Director Research
Systems

Katie O’Neil, IRB Analyst

DHDPS:

Sola Odesina, HRPP
Education & Compliance
Specialist

Justine Budhram, Staff
Assistant

SPA:
Louann D’Angelo, Senior
Grant Manager
Iris Valentin, Post Award
Financial Analyst
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Notable recent published papers
Narayanaswamy V, Pentecost BT,
Schoen CN, Alfandari D, Schneider
SS, Baker R, Arcaro KF. Neutralizing Antibodies and Cytokines
in Breast Milk After Coronavirus
Disease 2019 (COVID-19) mRNA
Vaccination. Obstet Gynecol. 2022
Feb 1;139(2):181-191. doi: 10.1097/
AOG.0000000000004661.
Arenas J, Becker S, Seay H, Frisard
C, Hoque S, Spano M, Lindenauer
PK, Sadasivam RS, Pbert L, Trivedi
M. A response to COVID-19 school
closures: the feasibility of a schoollinked text message intervention
as an adaptation to school-supervised asthma therapy. Pediatr
Pulmonol. 2022 Feb 1. doi: 10.1002/
ppul.25851. Epub ahead of print.
Evans EA, Wilson D, Friedmann
PD. Recidivism and mortality after
in-jail buprenorphine treatment for
opiod use disorder. Drug Alcohol
Depend. 2022 02 01; 231:109254.
PMID: 35063323
Engelman DT, Crisafi C, Hodle T,
Stiles J, Nathanson BH, Zarbock
A, Grant MC. Situational Awareness of Opioid Consumption: The
Missing Link to Reducing Dependence After Surgery? Anesth
Analg. 2022 Feb 2. doi: 10.1213/
ANE.0000000000005923. Epub
ahead of print.
Pack QR, Shea M, Brawner CA,
Headley S, Hutchinson J, Madera
H, Keteyian SJ. Exercise Prescription Methods and Attitudes in
Cardiac Rehabilitation: A NATIONAL SURVEY. J Cardiopulm Rehabil
Prev. 2022 Feb 18. doi: 10.1097/
HCR.0000000000000680. Epub
ahead of print.
Haessler S, Guo N, Deshpande A,
Zilberberg MD, Lagu T, Lindenauer PK, Imrey PB, Rothberg
MB. Etiology, Treatments, and
Outcomes of Patients With Severe
Community-Acquired Pneumonia
in a Large U.S. Sample. Crit Care
Med. 2022 Feb 22. doi: 10.1097/
CCM.0000000000005498. Epub
ahead of print.

Meet the Researcher

McCormick JL, Clark TA, Shea CM,
Hess DR, Lindenauer PK, Hill NS,
Allen CE, Farmer MS, Hughes AM,
Steingrub JS, Stefan MS. Exploring
Patient Experience with Noninvasive Ventilation: A Human-Centered Design Analysis to Inform
Planning for Better Tolerance.
Chronic Obstr Pulm Dis. 2022 Jan
10. doi: 10.15326/jcopdf.2021.0274.
Epub ahead of print.

patterns and trajectories recovery
in order to identify risk and
protective factors. Subsequently,
we can design interventions to
improve health. I also love to
think about methods and how
to improve study design and
analyses. My PhD dissertation was
on Propensity Score Methods.

Schoenfeld EM, Lin MP, Samuels-Kalow ME. Executive Summary
of the 2021 SAEM Consensus
Conference: From Bedside to
Policy: Advancing Social Emergency Medicine and Population Health
Through Research, Collaboration,
and Education. Acad Emerg Med.
2022 Jan 22. doi: 10.1111/acem.14451.
Epub ahead of print.

How do you see your research
improving care for patients? If we
can decrease barriers to treatment
for substance use disorder, we
can improve health and quality of
life.

Boos SC, Wang M, Karst WA,
Hymel KP. Traumatic Head Injury
and the Diagnosis of Abuse: A
Cluster Analysis. Pediatrics. 2021
Dec 13:e2021051742. doi: 10.1542/
peds.2021-051742. Epub ahead
of print.
Stefan MS, Pekow PS, Shea CM,
Hughes AM, Hill NS, Steingrub JS,
Farmer MJS, Hess DR, Riska KL,
Clark TA, Lindenauer PK. Update to the study protocol for an
implementation-effectiveness trial
comparing two education strategies for improving the uptake of
noninvasive ventilation in patients
with severe COPD exacerbation.
Trials. 2021 Dec 16;22(1):926. doi:
10.1186/s13063-021-05855-9.
Stefan MS, Pekow PS, Shea CM,
Hughes AM, Hill NS, Steingrub JS,
Farmer MJS, Hess DR, Riska KL,
Clark TA, Lindenauer PK. Update to the study protocol for an
implementation-effectiveness trial
comparing two education strategies for improving the uptake of
noninvasive ventilation in patients
with severe COPD exacerbation.
Trials. 2021 Dec 16;22(1):926. doi:
10.1186/s13063-021-05855-9.

Kopcsay KS, Marczak TD, Jeppson
PC, Cameron AP, Khavari R, Tefera
E, Gutman RE. Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP
trial. Int Urogynecol J. 2022 Jan 7.
doi: 10.1007/s00192-021-05030-3.
Epub ahead of print.

Reisinger-Kindle K, Qasba N,
Cayton C, Niakan S, Knee A, Goff
SL. Evaluation of rapid telehealth
implementation for prenatal and
postpartum care visits during
the COVID-19 pandemic in an
academic clinic in Springfield,
Massachusetts, United States of
America. Health Sci Rep. 2021 Dec
14;4(4):e455. doi: 10.1002/hsr2.455.

Vaidya R, Zitnik E, Kita T, Wagner
K, Marie PS, Visintainer P, Singh R.
Utilizing near infra-red spectroscopy to identify physiologic variations
during digital retinal imaging in
preterm infants. J Perinatol. 2022
Jan 11. doi: 10.1038/s41372-02101294-1. Epub ahead of print.

Dixon-Gordon KL, Waite EE,
Ammerman BA, Haliczer LA,
Boudreaux ED, Rathlev N, Cohen
AL. Learning from gain and loss:
Links to suicide risk. J Psychiatr
Res. 2021 Dec 15;147:126-134. doi:
10.1016/j.jpsychires.2021.12.016.
Epub ahead of print.

Sherry Weitzen, MD, PhD

Name: Sherry Weitzen, MD, PhD
Title/Academic Rank: Associate
Professor
Department: Family Medicine
Number of years at Baystate: 6
months. I recently moved back
to the area after 9 years at the
University of New Mexico in
Albuquerque.
What research training do you
have? MS in biostatistics, PhD
in epidemiology, and 1 year
fellowship at the CDC/National
Center for Health Statistics.
What got you interested in
research overall? Reading
“And the Band Played On” by
Randy Shilts, doing a summer
“internship” at Baystate in 1997
while I was a master’s student at
UMass Amherst, and working at
the National Center for Health
Statistics.
What is your area of research?
My current area of interest is
substance use disorder. As an
epidemiologist, I am interested in

The

What have been some of your
favorite research projects to fate
you have organized/participated
in? To date, I’m still finding my
way around at Baystate and have
enjoyed meeting people who are
passionate about research. In the
past, I have enjoyed analyzing
data from large data sets including
the SEER data, BRFSS, and NIS.
In addition, I have been part of
several studies looking at neonatal
opioid withdrawal syndrome
including the ACTNOWS
study which is a large multisite
randomized control trial evaluating
the effectiveness of Eat-SleepConsole for infants prenatal
exposed to opioids.
What do you like most about
your job? Learning about the
Franklin Country community
and meeting people who are
passionate about improving health
care for people who live here.
What do you do to unwind
outside of work? I love to run but
have slowed down in recent times.
Other activities I enjoy are reading,
doodling, and making jewerly.

Innovator

We are interested in ensuring that Baystate employees and patients
(and their families) are aware of the important research that goes on at
Baystate and how it contributes to better patient care. The Innovator
welcomes feedback and story ideas. Contact Matthew Hamel at
matthew.hamel@baystatehealth.org to submit yours.

